332 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
VRTX Vertex Pharmaceuticals Incorporated $176.08 $45B Downtrend
Article Searches
Your Daily Pharma Scoop: Catalyst Positive, JNJ Succeeds, Blue Chips Support Tilray https://seekingalpha.com/article/4200307-daily-pharma-scoop-catalyst-positive-jnj-succeeds-blue-chips-support-tilray?source=feed_sector_healthcare Aug 18, 2018 -
Lilly (LLY) Hits 52-Week High, Can the Run Continue? http://www.zacks.com/stock/news/318540/lilly-lly-hits-52-week-high-can-the-run-continue?cid=CS-ZC-FT-318540 Aug 17, 2018 - Lilly (LLY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Stocks To Watch: Any Privacy For Tesla? https://seekingalpha.com/article/4197968-stocks-watch-privacy-tesla?source=feed Aug 11, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Spectrum (SPPI) Earnings and Sales Miss Estimates in Q2 http://www.zacks.com/stock/news/317451/spectrum-sppi-earnings-and-sales-miss-estimates-in-q2?cid=CS-ZC-FT-317451 Aug 10, 2018 - Spectrum (SPPI) reports wider-than-expected loss in the second quarter and misses on revenues. Rolontis successful in second phase III study.
Vertex Pharmaceuticals (VRTX) Q2 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4190225-vertex-pharmaceuticals-vrtx-q2-2018-results-earnings-call-transcript?source=feed_sector_healthcare Jul 25, 2018 - Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)Q2 2018 Earnings CallJuly 25, 2018 4:30 pm ETExecutivesMichael Partridge - Vertex Pharmaceuticals, Inc.Jeffrey M. Leiden, M.D., Ph.D. - Vertex Pharmaceuticals
Vertex Pharmaceuticals Incorporated 2018 Q2 - Results - Earnings Call Slides https://seekingalpha.com/article/4190191-vertex-pharmaceuticals-incorporated-2018-q2-results-earnings-call-slides?source=feed_sector_healthcare Jul 25, 2018 - The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2018 Q2 earnings call.
Vertex Pharmaceuticals: Opportunities And Dangers https://seekingalpha.com/article/4189486-vertex-pharmaceuticals-opportunities-dangers?source=feed_sector_healthcare Jul 24, 2018 - Vertex has a high P/E ratio of 214, so is priced to perfection.Vertex saw a big dip in 2016 after Incivek revenue dropped.Successful expansion in and beyond Cystic Fibrosis should keep earning growing
Crispr Therapeutics: Elucidating The Significance Of The Mice Exploratory Finding https://seekingalpha.com/article/4189363-crispr-therapeutics-elucidating-significance-mice-exploratory-finding?source=feed_sector_healthcare Jul 24, 2018 - Crispr Therapeutics is a highly robust grower powered by the sound underlying science and strong catalysts.Leveraging the highly safe and efficacious (CRISPR/Cas9) gene-editing system, the company is
Pharma/Biotech Stock Q2 Earnings on Jul 25: GILD, VRTX & GSK http://www.zacks.com/stock/news/312876/pharma-biotech-stock-q2-earnings-on-jul-25-gild-vrtx-gsk?cid=CS-ZC-FT-312876 Jul 24, 2018 - The going has been good for the pharma giants, which reported second-quarter results so far. Let us see what is in store for biotech bigwig GILD, VRTX and large-cap pharma company GSK.
Applied Genetic Technologies Corporation: Near-Term Run Up Expected https://seekingalpha.com/article/4189316-applied-genetic-technologies-corporation-near-term-run-expected?source=feed_sector_healthcare Jul 23, 2018 - Shares are trading at roughly a third of the original IPO price. Recent accumulation is indicative of further upside in the near term. Pessimism and past setbacks have led to an incredibly cheap valua

Pages: 123456...34

Page 1>

Related Companies

Name Exchange Price Mkt Cap
ZTS Zoetis Inc. NYSE $91.47 $44.26B
REGN Regeneron Pharmaceuticals, Inc. NASDAQ $374.26 $40.37B
SHPG Shire plc NASDAQ $170.42 $51.94B
AGN Allergan plc. NYSE $185.6 $62.93B
CELG Celgene Corporation NASDAQ $90.37 $63.56B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Vertex Pharmaceuticals Incorporated